SBIR/STTR Research Award

Chemokine-receptor expression profiling in biological samples from human clinical trials

Award identifier ebb6836a07a6832db10aa7bbbbe34232b9997fd3a93fbb8fa36928f2e55d7b48Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$280,001

Program and phase

SBIR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Plumeria Therapeutics, Inc.
Proposal award date
2018-09-01
Contract end date
2019-02-28
UEI
EMZ9GH4XKEJ4
Solicitation number
PA19-029
Topic code
NINDS

Research abstract

Project Summary AbstractChronic pain is a major healthcare burdenrepresenting economic costs of up to $B per yearmore than cancerdiabetesand heart diseasePain is a highly heterogeneous condition comprising neuropathicnociceptive and inflammatory componentsand patient responses to currently available drugs vary greatlyA very promising approach to target various forms of pain is through antagonism of key players in neuro inflammationSpecificallythe chemokine receptor systema complex network of overdifferent receptors and overligandsis integral to neuroinflammatory processes and the pharmaceutical industry had been very active in developing compounds targeting individual receptors in the networkHoweverthe biological complexityligand promiscuityand receptor redundancy of the chemokine receptor system has precluded successful clinical development of the compounds and many pharma have exited the pain therapeutic areaA major limitation of successful targeting of this network is sufficient understanding of the molecular and cellular dynamics of the chemokine networkand how specific receptors vary in chronic pain conditionsIn a funded SBIR studywe aim to determine the genetic expression of a heterogenous chemokine receptor utilizing human clinical samples collected in a clinical trial evaluating a receptor antagonistThis application is to participate in i Corps program at NIH Project NarrativeChronic pain results in sufferingreduced quality of lifeand significant healthcare burdenswith an estimated annual economic cost up to $BNeuropathy and neuroinflammatory processes affected by the chemokine receptor system represent a promising area to treat various forms of chronic pain and these have attracted large investments in recent yearsWe aim to develop a deeper biological understanding of the receptor dynamics in this system using human samples collected from clinical trials evaluating an investigational drug antagonist for the receptorThis application is to participate in i Corps program at NIH

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

3 SBIR/STTR records share this UEI (2018–2025). Reported award amounts total $2,480,129. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.